Prevention is better than the cure: Risk management of COVID-19

• Published in: Journal of Risk and Financial Management
• Main Author: McAleer, Michael
• Format: Article in Journal/Newspaper
• Language: English
• Published: Basel: MDPI 2020
• Subjects: ddc:330; clinical trials; COVID-19; cures; MERS; risk management; SARS; vaccines; Antarc*; Antarctica
• Online Access: http://hdl.handle.net/10419/239134; https://doi.org/10.3390/jrfm13030046

A novel coronavirus was reported to the World Health Organization (WHO) in China on 31 December 2019. The WHO named the disease COVID-19 on 11 February 2020. As of 26 February 2020, the disease has been detected on all continents, except for Antarctica. Daily updates on COVID-19 since early February 2020 have made headline news worldwide for much of 2020. This editorial evaluates risk management based on the Global Health Security (GHS) Index of global health security capabilities in 195 countries. The GHS Index lists the countries best prepared for an epidemic or pandemic. COVID-19 is compared with two related coronavirus epidemics, SARS and MERS, in terms of the number of reported human infections, deaths, countries, major country clusters, timelines, and the likelihood of discovering a safe, effective, and approved vaccine.